Cardinal Health, Inc. Q2 2026 Earnings Recap

CAH Q2 2026 February 5, 2026

Get alerts when CAH reports next quarter

Cardinal Health delivered a robust second quarter in fiscal 2026, showcasing exceptional double-digit earnings growth across all segments, propelled by strong operational execution and increasing demand in specialty solutions.

Earnings Per Share Beat

$2.63 vs $2.34 est.

+12.4% surprise

Revenue Beat

65627000000 vs 65079160000 est.

+0.8% surprise

Market Reaction

1-Day -0.38%

5-Day -5.33%

30-Day -0.37%

See CAH alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue surged 19% to $66 billion, primarily driven by the pharmaceutical and specialty solutions segment.
Non-GAAP diluted EPS increased 36% year-over-year to $2.63, with an updated EPS guidance raised to $10.15 to $10.35 for the fiscal year.
Acquisition of Solaris Health enhances the company's specialty platform, underlining a strategic focus on high-growth, higher-margin areas.
Operating earnings rose 38% to $877 million, reflecting disciplined expense management alongside robust revenue growth.
The company repurchased $375 million in shares, achieving its full-year target of $750 million in buybacks.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit CAH on AllInvestView.

Previous Q4 2025

Next Q3 2026